Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations.


Journal

The Hastings Center report
ISSN: 1552-146X
Titre abrégé: Hastings Cent Rep
Pays: United States
ID NLM: 0410447

Informations de publication

Date de publication:
11 2021
Historique:
pubmed: 10 11 2021
medline: 22 12 2021
entrez: 9 11 2021
Statut: ppublish

Résumé

When the U.S. Food and Drug Administration fully approved the Pfizer-BioNTech Covid-19 vaccine for people sixteen and older, questions arose. Parents, pediatricians, and the media wondered whether Covid-19 vaccines could be used off-label-and whether they should be. The American Academy of Pediatrics cautioned against pediatric off-label use of the vaccine, and the vaccine provider agreement from the Centers for Disease Control and Prevention appears to prohibit it. After briefly contextualizing ethical and legal precedents regarding off-label use, we offer an analysis of the ethical permissibility of and considerations for pediatric off-label Covid-19 vaccination based on individual benefits, risks, and available alternatives. Our analysis challenges the ethics of a blanket prohibition on off-label pediatric Covid-19 vaccination, as it limits clinician ability to provide care they may determine to be clinically and ethically appropriate. At the same time, our analysis acknowledges that Covid-19 creates population-level ethical considerations that are at times in tension with individual health interests.

Identifiants

pubmed: 34750807
doi: 10.1002/hast.1296
pmc: PMC8653287
doi:

Substances chimiques

COVID-19 Vaccines 0
BNT162 Vaccine N38TVC63NU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-32

Informations de copyright

© 2021 The Hastings Center.

Références

J Am Acad Psychiatry Law. 2021 Mar;49(1):53-59
pubmed: 33234538
Pharmacoepidemiol Drug Saf. 2011 Sep;20(9):895-902
pubmed: 21774029
BMJ Open. 2016 Aug 31;6(8):e012803
pubmed: 27580838
New Sci. 2021 Feb 27;249(3323):10-11
pubmed: 33686318
Rev Obstet Gynecol. 2011 Summer;4(2):39-41
pubmed: 22102925
Nephrol News Issues. 2007 Jun;21(7):43-4, 46-7
pubmed: 17623984
Mayo Clin Proc. 2012 Oct;87(10):982-90
pubmed: 22877654
Hastings Cent Rep. 2021 Nov;51(6):27-32
pubmed: 34750807
Arch Pediatr Adolesc Med. 2007 Mar;161(3):282-90
pubmed: 17339510
Acad Pediatr. 2009 Mar-Apr;9(2):81-8
pubmed: 19329098
Clin Pharmacol Ther. 2020 Aug;108(2):182-184
pubmed: 32311763
Ann Intern Med. 2009 Mar 3;150(5):344-7
pubmed: 19221367
Hosp Pediatr. 2019 Mar;9(3):186-193
pubmed: 30745323

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH